BioPacific Conference 2010 Agenda

Theme: Drug Discovery and Development in Changing Times

May 08, 2010, Saturday, Foster City, California

8:00 – 9:00am Registration and Vendor Exhibits (with coffee and refreshments)
9:00 – 9:05am Welcome

Wei Dong, M.D., Ph.D. (CABS President-Elect)
9:05 – 9:15am State of the

Shichang Miao, Ph.D. (CABS President)
Session I: Global Discovery and Development
Co-chairs: Charlene Liao, Ph.D., Cheni Kwok, Ph.D., CLP

9:15 – 9:40am Small Molecule Drug Discovery in the Modern World
Michael D. Varney, Ph.D, Senior Vice President,
Small Molecule Drug Discovery, Genentech
9:40 – 10:05am New Medicines
for the Developing World

Richard Chin, M.D., CEO, Institute for OneWorld Health
10:05 – 10:30am Singapore:Biopolis of Asia
Ih-Ming Chan, Center Director, Americas, Singapore Economic Development Board
10:30 – 10:55am Opportunities and Challenges in Global Drug Development –
Including China as a Key Country

Michael Doherty, Global Head of Regulatory
Affairs, Hoffmann-La Roche Ltd and Genentech
10:55 – 11:15am Break, Networking & Vendor Exhibits
Session II: Advances in Neuroscience
Co-chairs: Zhonghua Pei, Ph.D.,  Hua Tu, Ph.D.
11:15 – 11:40am Mapping Olfaction in the Fly and Mouse

Liqun Luo,
Professor, HHMI Investigator, Stanford University
11:40 – 12:05pm Neuroscience at Genentech  
Morgan Sheng, MBBS, Ph.D., Vice President of
Neuroscience, Genentech
12:05 – 12:20pm Diamond Sponsor Presentation
Suzhou-Nantong Science and Technology Park
12:20 – 1:20pm Lunch, Networking and Vendor Exhibits

Session III: Promising Pipelines and Technologies 
Co-chairs: Shichang Miao, Ph.D., Leping Li, Ph.D.  
1:20 – 1:45pm Expanding Access to Patients in Need Around
the World

Gregg H. Alton, J.D., Executive Vice President, Corporate and Medical Affairs, Gilead
1:45 – 2:10pm Chemkines and Chemokine Receptors:
A Rich Area for New Opportunities in Drug Discovery

Thomas J. Schall, Ph.D., President and CEO, ChemoCentryx

2:10 – 2:35pm Molecular Motors and Beyond: Novel Targets for Small Molecule Drug

Bradley P. Morgan, Ph.D., Vice President of
Chemistry, Cytokinetics

2:35 – 3:00pm Unlocking the Power of RNA Biomarkers for Personalized Medicine
Yuling Luo, Ph.D., President and CEO,
Advanced Cell Diagnostics
3:00 – 3:15pm Platinum Sponsor Presentation
A Fully Integrated CRO from Drug Discovery to IND Filing
Boliang Lou, Ph.D., Chairman and CEO, Pharmaron
3:15 – 3:35pm Break, Networking & Vendor Exhibits
Session IV: Investment and Business Opportunities in China
Co-chairs: Connie Sun, Ph.D., Janet Xiao,
Ph.D., J.D. 
3:35 – 3:55pm Keys for Life Sciences Investing in China:
What You Need to Know

Charles Comey, Managing
Partner, Morrison Foerster’s Shanghai Office  
3:55 – 4:15pm Enhancing International Competence of Chinese Biotech Enterprise by Promoting
International Cooperation

Bing Zeng, Vice President of Sino-Pharm, and Sino-PHRDA Delegation Leader
4:15 – 4:35pm China Drug Discovery Landscape Overview
Helen Chen, Ph.D., Director and Partner, Head
of China Life Sciences, L.E.K Consulting, Shanghai
4:35 – 4:55pm New Drug R&D “in China, for Global”
Dajun Yang, MD, Ph.D., President and CEO, Ascentage Pharma Group Corp.
Gold Sponsors’ Presentations
Co-chairs: Titan Gu, Ph.D.,  Zhenhai Shen, Ph.D., MBA
4:55 – 5:30pm Rules Based
                         Wuxi Apptec
Optivia/Primax                                        Sundia
Tianjin Port Free Trade Zone/Tianjin Institute of Industrial Biotechnology, CAS
5:30 – 6:00pm Break, Networking & Vendor Exhibits
Evening Session: The Pharmaceutical Industry in China: the Present and the Future
Co-organized with China Pharmaceutical Research and Development
Association (Sino-PHRDA)
Co-chairs: Wentao Zhang, Ph.D., Janet Xiao, Ph.D.
6:00 – 7:00pm Dinner Served

6:30 – 6:40pm Welcome Remarks
Shichang Miao, Ph.D., CABS President
6:40 – 9:00pm Presentations from the Sino-PHRDA Delegation

Healthcare Reform and
Opportunities for the Pharmaceutical Industry in China

Ruilin Song,  Executive President,
China Pharmaceutical Research and Development Association
 中国医药工业科研开发促进会  执行会长

Development of Antibiotics
in China

Baxian Yi, General manager, Sichuan Industrial Institute of Antibiotics
易八贤, 中国医药集团总公司四川抗菌素工业研究所 所长

Development Status and
Trends of  the Biopharmaceutical
Industry of Shanghai

Shaoxiong Chen, Secretary General, Shanghai
Biopharmaceutical Industry Association
陈少雄, 上海市生物医药行业协会副会长兼秘书长

Kelun: A Rapidly-developing
Pharmaceutical Company

Long Liang, President, Sichuan Kelun Pharmaceutical Research Ltd.
梁隆, 四川科伦药物研究有限公司总经理

Biolake and Central China’s
Biotech Development

Zhongning Yan, Deputy Director, Wuhan BioLake (武汉光谷生物城)
闫忠宁 武汉国家生物产业基地建设管理办公室副主任

Overview of LUYE Pharma and Yantai Biotech Research Park-BiOasis
Youxin Li,
Executive Vice-President, Research and Development, Luye pharma Group
李又欣, 烟台绿叶集团副总裁

The Forefront of the Global
Cancer Industry Development

Ruihua Jiang, Vice President, Zhendong Pharmaceutical Company
蒋瑞华, 山西振东制药股份有限公司副总经理

9:00 – 9:20pm Panel Discussions

9:20pm Adjourned